Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Health & MedicineOne-Off3m
Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actual
No 56.3%
Pronosticadores
17
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 14 horas
Desactualizado5 oct 24, 2:42 UTC2 ene 27, 4:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will the FDA approve any psychedelic substance for medical use this year?
Kalshi[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
Manifold MarketsWill the FDA approve camizestrant for advanced breast cancer?
KalshiWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurReglas
https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate
- Resolves YES if any currently known psychedelic substance (as of October 4th, 2024) is FDA approved for any category of mental disorder by January 1st 2027.
- The caveat is mainly to avoid the possibility that any subsequent drug development produces a treatment for a mental disorder that is later found out to have psychedelic effects.
- Possible clarification from creator (AI generated): Market will resolve as N/A if the FDA is abolished before January 1st 2027.
Mercados abiertos
Health & Medicine
POLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Volumen total
- 650,1 mil €
- Volumen 24h
- 29,7 mil €
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volumen total
- 15,6 M €
- Volumen 24h
- 20,5 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volumen total
- 1,6 M €
- Volumen 24h
- 5,2 mil €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Volumen total
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Volumen total
- 915,1 mil €
- Volumen 24h
- 3,2 mil €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before 2027+8.0pt84%
- before April 202781%
- before December+1.0pt69%
+3 resultados más
- Volumen total
- 14,2 mil €
- Measles cases in 2026?
- New pandemic before 2028?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Which countries will have an Ebola case in 2026?
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027??
- Manifold Markets cotiza No al 56% a fecha de 8 de septiembre de 2026.
- ¿Cuándo se resuelve Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027??
- Está previsto que Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027? se resuelva el 2 de enero de 2027.
- ¿Cómo se liquida Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027??
- Manifold Markets liquida este mercado del siguiente modo: https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate